HN1998000102A - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number: HN1998000102A
Authority: HN; Honduras
Prior art keywords: soltrilized; sertralina; compositions; present; invention refers
Prior art date: 1997-07-01

Application number

HN1998000102A

Other languages

English (en)

Spanish (es)

Inventor

Pfizer Products Inc

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-07-01

Publication date

1999-01-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1998000102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-01 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-01-08 Publication of HN1998000102A publication Critical patent/HN1998000102A/es

Links

239000000203 mixture Substances 0.000 title abstract 2
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical group C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HN1998000102A 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina HN1998000102A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
HN1998000102A true HN1998000102A (es)	1999-01-08

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HN1998000102A HN1998000102A (es)	1997-07-01	1998-07-01	Composiciones solubilizadas de sertralina

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (fr)
JP (1)	JP2000514100A (fr)
KR (1)	KR100366373B1 (fr)
CN (1)	CN1261794A (fr)
AP (1)	AP1192A (fr)
AR (3)	AR015917A1 (fr)
AU (1)	AU742535B2 (fr)
BG (1)	BG103918A (fr)
BR (1)	BR9810739A (fr)
CA (1)	CA2290974C (fr)
CO (1)	CO4940495A1 (fr)
DZ (1)	DZ2548A1 (fr)
EA (1)	EA002481B1 (fr)
HN (1)	HN1998000102A (fr)
HR (1)	HRP980377A2 (fr)
HU (1)	HUP0002236A3 (fr)
ID (1)	ID23429A (fr)
IL (1)	IL133076A (fr)
IS (1)	IS5260A (fr)
MA (1)	MA24587A1 (fr)
NO (1)	NO996520L (fr)
OA (1)	OA11243A (fr)
PA (1)	PA8454301A1 (fr)
PE (1)	PE97199A1 (fr)
PL (1)	PL337804A1 (fr)
SK (1)	SK181099A3 (fr)
TN (1)	TNSN98124A1 (fr)
TR (1)	TR199903297T2 (fr)
TW (1)	TW550087B (fr)
UA (1)	UA67741C2 (fr)
UY (1)	UY25071A1 (fr)
WO (1)	WO1999001120A1 (fr)
YU (1)	YU68299A (fr)
ZA (1)	ZA985708B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ3227A1 (fr)	1999-12-23	2001-07-05	Pfizer Prod Inc	Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
MXPA03001771A (es)	2000-08-30	2003-06-04	Pfizer Prod Inc	Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
CN101631593B (zh) *	2007-03-12	2014-08-13	帝斯曼知识产权资产管理有限公司	化妆品组合物
BR112012003592B8 (pt)	2009-08-19	2021-05-25	Eisai R&D Man Co Ltd	composição farmacêutica contendo derivado de quinolina
US20130035344A1 (en) *	2009-12-29	2013-02-07	Kowa Co., Ltd.	Pharmaceutical composition for oral administration
JPWO2011081117A1 (ja) *	2009-12-29	2013-05-09	興和株式会社	経口投与用固形医薬組成物
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) *	2022-05-20	2025-03-21	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
ATE96999T1 (de) *	1989-08-30	1993-11-15	Pfizer	Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/fr not_active Ceased
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 CA CA002290974A patent/CA2290974C/fr not_active Expired - Fee Related
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active Expired - Fee Related
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/fr not_active Withdrawn
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/fr active
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
IL133076A (en)	2003-12-10
CO4940495A1 (es)	2000-07-24
ZA985708B (en)	2000-01-10
CA2290974A1 (fr)	1999-01-14
PA8454301A1 (es)	2000-09-29
BR9810739A (pt)	2000-09-12
YU68299A (sh)	2002-06-19
ID23429A (id)	2000-04-20
NO996520D0 (no)	1999-12-28
AP1192A (en)	2003-07-23
SK181099A3 (en)	2000-07-11
BG103918A (en)	2000-07-31
EA199900962A1 (ru)	2000-08-28
AR040279A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
AU7544898A (en)	1999-01-25
MA24587A1 (fr)	1998-12-31
AR040280A2 (es)	2005-03-23
UA67741C2 (uk)	2004-07-15
KR20010013365A (fr)	2001-02-26
AR015917A1 (es)	2001-05-30
EA002481B1 (ru)	2002-06-27
OA11243A (en)	2003-07-24
HUP0002236A3 (en)	2003-12-29
KR100366373B1 (ko)	2003-01-14
TNSN98124A1 (fr)	2005-03-15
AU742535B2 (en)	2002-01-03
DZ2548A1 (fr)	2003-02-08
PL337804A1 (en)	2000-09-11
EP0999829A1 (fr)	2000-05-17
NO996520L (no)	2000-02-29
HRP980377A2 (en)	1999-04-30
HUP0002236A2 (hu)	2003-08-28
TW550087B (en)	2003-09-01
AP9801280A0 (en)	1998-06-30
CA2290974C (fr)	2004-04-27
IL133076A0 (en)	2001-03-19
TR199903297T2 (xx)	2000-07-21
WO1999001120A1 (fr)	1999-01-14
UY25071A1 (es)	2000-12-29
IS5260A (is)	1999-11-19
PE97199A1 (es)	1999-10-05
CN1261794A (zh)	2000-08-02

Publication	Publication Date	Title
HN1999000089A (es)	1999-11-03	Formulaciones de ziprasidona
HN1998000086A (es)	1999-03-08	Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000036A (es)	1999-08-23	Compuesto de pirazina
HN1998000011A (es)	1999-02-09	Derivados de acidos arilsulfonilaminohidroxamicos
HN1999000155A (es)	2000-01-12	4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000090A (es)	1997-12-26	Compuestos de piridilpirrol
HN1997000023A (es)	1997-06-05	Derivados de lactama
HN1997000166A (es)	2001-06-06	1-arilpirazoles plaguicidas
HN1999000066A (es)	1999-09-29	Formulaciones farmaceuticas
HN1998000132A (es)	1999-02-09	Combinaciones terapeuticas
HN1998000124A (es)	1999-02-09	Terapia de combinacion
HN1998000057A (es)	1999-01-08	Derivados de nicotinamida
HN1997000126A (es)	1997-12-26	Derivados de indazol
HN1998003689A (es)	1999-01-08	Azetidinas
HN1997000097A (es)	1997-12-26	Piridinas condensadas con heterociclicos
HN1998000030A (es)	1998-10-22	2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000106A (es)	1999-01-08	Composiciones parenterales de alatroflaxacino
HN1998000158A (es)	1999-02-09	Isoquinolinas
HN1998000028A (es)	1999-02-09	Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000199A (es)	2000-11-03	Agentes terapeuticos
HN1998000045A (es)	1999-03-19	Composiciones farmaceuticas
HN1998000193A (es)	2000-04-05	Compuestos de triazina
HN1998000165A (es)	1999-02-09	Polimorfos dofetilina
HN1999000202A (es)	2000-06-13	Derivados de higromicina
HN1997000119A (es)	1997-12-26	Formulaciones repelente